This Canadian Health and Wellness Stock Is Riding Serious Tailwinds That Could Send Shares Soaring

Jamieson Wellness Inc. (TSX:JWEL) is an underrated business with a solid growth strategy and a tonne of catalysts. Here’s why investors would be wise to pick up shares today.

| More on:
The Motley Fool
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

As the cold and flu season comes around the corner, it’s expected that many Canadians will be taking supplements to beef up their immune systems to combat the nasty bugs that are ready to be unleashed. Nobody wants a cold or the flu, but we all know if a family member gets it, then we’re likely next.

Fortunately, there is a way to profit from one of the grossest times of the year!

Jamieson Wellness Inc. (TSX:JWEL) is a vitamin, mineral, and health supplement manufacturer that has been in business for nearly a century. It’s the go-to brand when it comes to supplements, as many Canadians gravitate towards Jamieson’s green-cap bottle when they’re at the health and wellness section of the grocery store. Jamieson is a trusted brand that’s loved not just by Canadians, but in various international markets as well.

The company recently had its IPO earlier this year. Although I’m not a fan of investing in stocks that haven’t been public for at least three years, I think Jamieson is a worthy exception because of the fairly predictable nature of the business in addition to many medium- to long-term catalysts that could send the stock flying to much higher levels.

Jamieson’s new cold and flu product could send sales flying

Back to the cold and flu season. It’s like the next market correction: everyone dreads it, but it’s coming whether you’re ready or not. Jamieson Wellness is releasing a new cold and flu product called “Cold Fighter” to help Canadians prepare for the upcoming sick season.

Do you feel like you’re starting to come down with something? The Cold Fighter chewable is marketed to fight early signs of cold and flu symptoms in addition to relieving cold symptoms if you’ve already got the full-blown cold. Taking the chewable once per day is also marketed to reduce the duration of colds.

I don’t know about you, but this product sounds like a must-have for every medicine cabinet out there. I think the product will be one of Jamieson’s top sellers for the fall season, and that could mean a nice bump to the company’s third-quarter numbers.

Baby boomers are getting older and need more supplements

Another gradual long-term tailwind lies in the baby boomer generation, which is expected to be a gigantic consumer of vitamins, minerals, and other supplements. The Canadian vitamin industry was worth ~$431 million last year and going forward, it’s expected that it’ll be worth even more as baby boomers continue to age. Jamieson has a dominant position in the Canadian vitamin market, but there’s still a lot of room to run, and as the company releases new products like Cold Fighter chewables, I believe the company is setting itself up to be a behemoth which could control more than half of the Canadian vitamin market in a few years (Jamieson controls about a quarter of this market today).

Bottom line

Jamieson is a wonderful business with a respected brand, a promising growth profile, and several tailwinds to be excited about. Although the stock is just a few months off its IPO, I think investors would be wise to accumulate a position gradually over time to get some skin in the game.

Stay smart. Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any stocks mentioned.  

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »